(Q46138908)

19 December 2017

title

Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience (English)

1 reference

19 December 2017

1 reference

1

1 reference

19 December 2017

Gary B. Calandra

10

object named as

G Calandra

1 reference

19 December 2017

author name string

A Dunn

2

1 reference

19 December 2017

B Hayes-Lattin

3

1 reference

19 December 2017

K Hansen

4

1 reference

19 December 2017

L Hansen

5

1 reference

19 December 2017

K Lanier

6

1 reference

19 December 2017

V Nelson

7

1 reference

19 December 2017

T Kovacsovics

8

1 reference

19 December 2017

J Leis

9

1 reference

19 December 2017

R T Maziarz

11

1 reference

19 December 2017

language of work or name

English

0 references

publication date

2 February 2009

1 reference

19 December 2017

Bone Marrow Transplantation

published in

1 reference

19 December 2017

volume

43

1 reference

19 December 2017

issue

12

1 reference

19 December 2017

page(s)

909-917

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2008.409

exact match

0 references

cites work

It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

ATP-dependent activation of the intermediate conductance, Ca2+-activated K+ channel, hIK1, is conferred by a C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Neutrophil homeostasis: a new role for stromal cell-derived factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

BIOLOGY OF HEMATOPOIETIC STEM CELLS AND PROGENITORS: Implications for Clinical Application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.409

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.409

1 reference

19 December 2017

Dimensions Publication ID

1024209668

0 references

1 reference

19 December 2017